![cover image](https://wikiwandv2-19431.kxcdn.com/_next/image?url=https://upload.wikimedia.org/wikipedia/commons/thumb/e/e9/BlueAIONLabs.png/640px-BlueAIONLabs.png&w=640&q=50)
AION Labs
From Wikipedia, the free encyclopedia
AION Labs is an Israeli[1] venture studio focused on the adoption of artificial intelligence (AI) and machine learning (ML) in pharmaceutical discovery and development processes.[2][3][1][4]
Quick Facts Company type, Industry ...
![]() | |
Company type | Venture Studio |
---|---|
Industry | AI, Machine Learning, Pharmaceutical Discovery, Drug Development |
Founded | 2021; 3 years ago (2021) |
Key people | Mati Gill (CEO), Yair Benita (CTO) |
Website | aionlabs |
Close
It is backed by eight major companies in the pharmaceutical, technology, and investing sectors.[5][6][7] This partnership includes pharmaceutical companies AstraZeneca,[8] Merck KGaA,[9] Pfizer,[10] and Teva Pharmaceuticals;[11] venture capital firms Israel Biotech Fund[12] and Amiti Ventures;[13] strategic partner Amazon Web Services;[14] and independent research institute BioMed X,[15] with support from the Israel Innovation Authority.[16]